ZA201000987B - Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith - Google Patents

Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith

Info

Publication number
ZA201000987B
ZA201000987B ZA2010/00987A ZA201000987A ZA201000987B ZA 201000987 B ZA201000987 B ZA 201000987B ZA 2010/00987 A ZA2010/00987 A ZA 2010/00987A ZA 201000987 A ZA201000987 A ZA 201000987A ZA 201000987 B ZA201000987 B ZA 201000987B
Authority
ZA
South Africa
Prior art keywords
benzothiazol
isoxazol
morpholin
imidazo
ethoxy
Prior art date
Application number
ZA2010/00987A
Inventor
Valeriya N Smolenskaya
Melanie J Roe
Stephen D Parent
Wei Lai
Shripad Bhagwat
Alan Schwartz
Original Assignee
Ambit Biosciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2008/010884 external-priority patent/WO2009038757A2/en
Application filed by Ambit Biosciences Corp filed Critical Ambit Biosciences Corp
Publication of ZA201000987B publication Critical patent/ZA201000987B/en

Links

ZA2010/00987A 2007-09-19 2010-02-10 Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith ZA201000987B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94463507P 2007-09-19 2007-09-19
PCT/US2008/010884 WO2009038757A2 (en) 2007-09-19 2008-09-19 Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith

Publications (1)

Publication Number Publication Date
ZA201000987B true ZA201000987B (en) 2011-04-28

Family

ID=61026573

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2010/00987A ZA201000987B (en) 2007-09-19 2010-02-10 Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith

Country Status (1)

Country Link
ZA (1) ZA201000987B (en)

Similar Documents

Publication Publication Date Title
IL203926A (en) Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof and uses thereof
EP1845086A4 (en) N-(2-substituted phenyl)-n-methoxycarbamates and their preparation as well as use
SG10201401826TA (en) Formulation comprising metformin and vildagli ptin
IL212308A0 (en) Solid forms of n-(4-(7-azabicyclo[2.2.1] heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide and compositions comprising the same and uses thereof
HK1117768A1 (en) Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
LTPA2017031I1 (en) 8 - [{1- (3,5-Bis- (Trifluoromethyl) phenyl) ethoxy} -methyl] -8-phenyl-1,7-diaza-spiro [4.5] decan-2-one hydrochloride salt and the method of its preparation
EG25201A (en) 4-cyclopropyl-1,2,3- thiadiazole compound, agrohorticultural plant disease controlling agent and method of using the same
PL1931660T3 (en) Phenyl-[1,2,4]-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals
EP1932836A4 (en) Isoxazoline-substituted benzamide compound and harmful organism-controlling agent
ZA200710342B (en) The preparation and use of compounds as aspartyl protease inhibitors
TW200613479A (en) Coating formulation having improved rheological properties
EP1838165A4 (en) Methods for enhancing the palatability of compositions for consumption by animals
EP1954685A4 (en) Furoxan compounds, compositions and methods of use
AU2006321904A8 (en) 1, 1, 3-trioxo-1 , 2 , 5-thiadiazolidines and their use as PTP-ases inhibitors
HK1105202A1 (en) Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient
HK1116482A1 (en) Oxazolidinone derivatives and use thereof as antibiotics
IL192328A (en) Yeast cell walls for use in the treatment and protection of plants against disease caused by pathogenic agents and compositions comprising said yeast cell walls
BRPI0810323A2 (en) "COMBINATION OF 5-CARBOXYLIC PYROLIDONE ACID, USE OF 5-CARBOXYLIC PYROLIDONE ACID, COMPOSITION AND USE"
NZ627631A (en) Benzoheterocyclic compounds and use thereof
GB0502787D0 (en) Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use
EP1885365A4 (en) Treatment of sepsis and inflammation with alpha2a adrenergic antagonists
EP1791423A4 (en) Compositions and methods for the management of hyperproliferative dermatological conditions
ZA201000987B (en) Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith
PL1904490T3 (en) Ethanolamine salt of n- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-0xadiaz0le-2-yl]phenyl) pyridine-3- sulphonamide
WO2006122012A3 (en) Polymorphic forms of (s)- tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate